Satellos Bioscience
Tracked across 1 events · 10 articles · First seen Feb 05, 2026 · Last active Feb 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Satellos Bioscience Inc. successfully completed a public offering, raising approximately US$57.2 million. This capital infusion is intended to fund ongoing research and development activities, including advancing SAT-3247 through clinical trials, and for general corporate purposes. The offering also included the exercise of the underwriters' option to purchase additional shares, indicating strong market interest.
Feb 05, 2026 · 10 articles
Mark Nawacki
board member
↔
Satellos Bioscience
Mark Nawacki is a member of the board of directors of Satellos Bioscience Inc.
Franklin Berger
board member
↔
Satellos Bioscience
Franklin Berger is a member of the board of directors of Satellos Bioscience Inc
NEWSDESK
Track Satellos Bioscience live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard